# FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers

Source: https://onco.cc/trials/nct07478523/  
OnCo record `nct07478523` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of the registered interventions in gallbladder cancer and other biliary tract cancers, run by University Hospital, Bordeaux, now recruiting.

## Summary

FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers is a phase 2 interventional study registered as NCT07478523 by University Hospital, Bordeaux, with a registry enrolment figure of 120 participants, started 2026-04-21 and due to reach its primary completion in 2028-03-21. Interventions recorded: TEP-TDM au 68Ga-FAPI-46. Conditions listed: Cholangiocarcinoma, Pancreatic Adenocarcinoma. Sites: France. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: FAPDIG
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07478523
- Phase: 2
- Setting: Diagnostic Value of 68Ga-FAPI-46 PET/CT in the Initial Work-up of Pancreatic and Biliary Cancers Eligible to a Curative Treatment
- Sponsor: University Hospital, Bordeaux
- Enrolled: 120

## Sources

- ClinicalTrials.gov NCT07478523: https://clinicaltrials.gov/study/NCT07478523

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07478523.json